| Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement R Bharti, G Dey, M Mandal Cancer letters 375 (1), 51-61, 2016 | 243 | 2016 |
| Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform H Choudhury, B Gorain, S Karmakar, E Biswas, G Dey, R Barik, M Mandal, ... International Journal of Pharmaceutics 460 (1-2), 131-143, 2014 | 206 | 2014 |
| Antineoplastic and apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma S Das, KK Dey, G Dey, I Pal, A Majumder, S MaitiChoudhury, SC Kundu, ... Public Library of Science 7 (10), e46641, 2012 | 196 | 2012 |
| Marine lipopeptide Iturin A inhibits Akt mediated GSK3β and FoxO3a signaling and triggers apoptosis in breast cancer G Dey, R Bharti, G Dhanarajan, S Das, KK Dey, BNP Kumar, R Sen, ... Scientific reports 5 (1), 10316, 2015 | 134 | 2015 |
| Insights into molecular therapy of glioma: current challenges and next generation blueprint Y Rajesh, I Pal, P Banik, S Chakraborty, SA Borkar, G Dey, A Mukherjee, ... Acta pharmacologica sinica 38 (5), 591-613, 2017 | 126 | 2017 |
| Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy I Banerjee, K De, D Mukherjee, G Dey, S Chattopadhyay, M Mukherjee, ... Acta biomaterialia 38, 69-81, 2016 | 98 | 2016 |
| Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo A Parekh, S Das, S Parida, CK Das, D Dutta, SK Mallick, PH Wu, ... Oncogene 37 (33), 4546-4561, 2018 | 84 | 2018 |
| Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy R Bharti, G Dey, I Banerjee, KK Dey, S Parida, BNP Kumar, CK Das, I Pal, ... Cancer letters 388, 292-302, 2017 | 83 | 2017 |
| Overcoming Akt induced therapeutic resistance in breast cancer through siRNA and thymoquinone encapsulated multilamellar gold niosomes S Rajput, N Puvvada, BNP Kumar, S Sarkar, S Konar, R Bharti, G Dey, ... Molecular pharmaceutics 12 (12), 4214-4225, 2015 | 80 | 2015 |
| Diacerein-mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cancer R Bharti, G Dey, PK Ojha, S Rajput, SK Jaganathan, R Sen, M Mandal Oncogene 35 (30), 3965-3975, 2016 | 78 | 2016 |
| Microbial amphiphiles: a class of promising new-generation anticancer agents G Dey, R Bharti, R Sen, M Mandal Drug Discovery Today 20 (1), 136-146, 2015 | 70 | 2015 |
| Tailor-made temperature-sensitive micelle for targeted and on-demand release of anticancer drugs S Panja, G Dey, R Bharti, K Kumari, TK Maiti, M Mandal, S Chattopadhyay ACS Applied Materials & Interfaces 8 (19), 12063-12074, 2016 | 68 | 2016 |
| Successful delivery of docetaxel to rat brain using experimentally developed nanoliposome: a treatment strategy for brain tumor TK Shaw, D Mandal, G Dey, MM Pal, P Paul, S Chakraborty, KA Ali, ... Drug delivery 24 (1), 346-357, 2017 | 65 | 2017 |
| Dietary flavone chrysin (5, 7-dihydroxyflavone ChR) functionalized highly-stable metal nanoformulations for improved anticancer applications G Sathishkumar, R Bharti, PK Jha, M Selvakumar, G Dey, R Jha, ... RSC advances 5 (109), 89869-89878, 2015 | 52 | 2015 |
| Differential expression of IL-6/IL-6R and MAO-A regulates invasion/angiogenesis in breast cancer R Bharti, G Dey, AK Das, M Mandal British journal of cancer 118 (11), 1442-1452, 2018 | 51 | 2018 |
| Metal ion ornamented ultrafast light-sensitive nanogel for potential in vivo cancer therapy S Panja, G Dey, R Bharti, P Mandal, M Mandal, S Chattopadhyay Chemistry of Materials 28 (23), 8598-8610, 2016 | 51 | 2016 |
| Resensitization of Akt Induced Docetaxel Resistance in Breast Cancer by ‘Iturin A’ a Lipopeptide Molecule from Marine Bacteria Bacillus megaterium G Dey, R Bharti, AK Das, R Sen, M Mandal Scientific reports 7 (1), 17324, 2017 | 47 | 2017 |
| S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway KK Dey, R Bharti, G Dey, I Pal, Y Rajesh, S Chavan, S Das, CK Das, ... Cancer gene therapy 23 (11), 382-391, 2016 | 43 | 2016 |
| A peptide-modified solid lipid nanoparticle formulation of paclitaxel modulates immunity and outperforms dacarbazine in a murine melanoma model I Banerjee, M De, G Dey, R Bharti, S Chattopadhyay, N Ali, P Chakrabarti, ... Biomaterials science 7 (3), 1161-1178, 2019 | 42 | 2019 |
| Therapeutic implication of ‘Iturin A’ for targeting MD-2/TLR4 complex to overcome angiogenesis and invasion Goutam Dey, Rashmi Bharti, Probir Kumar Ojha, Ipsita Pal, Y. Rajesh ... Cellular Signalling, 2017 | 40 | 2017 |
Mahitosh MandalProfessor, School of Medical Science and Technology,Indian Institute of Technology, Kharagpur, IndiaVerified email at smst.iitkgp.ac.in
